Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA010738 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA010738, RRID:AB_1078100
- Product name
- Anti-ADAM17
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ADAM17, Gene description: ADAM metallopeptidase domain 17, Alternative Gene Names: CD156B, cSVP, TACE, Validated applications: IHC, ICC, Uniprot ID: P78536, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Prognostic value of ADAM17 in human gastric cancer
Yang J, Lee I, Huang C, Huang H, Wu Y, Chong Z, Chen J
International Journal of Molecular Sciences 2023;24(9):7703
International Journal of Molecular Sciences 2023;24(9):7703
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Fabbi M, Costa D, Russo D, Arenare L, Gaggero G, Signoriello S, Scambia G, Pisano C, Colombo N, Losito N, Filaci G, Spina A, Califano D, Scognamiglio G, Gadducci A, Mezzanzanica D, Bagnoli M, Ferrini S, Canzonieri V, Chiodini P, Perrone F, Pignata S
Diagnostics 2022;12(9):2118
Diagnostics 2022;12(9):2118
Prognostic value of ADAM17 in human gastric cancer
Zhang T, Zhu W, Huang M, Fan R, Chen X
Medical Oncology 2011;29(4):2684-2690
Medical Oncology 2011;29(4):2684-2690
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of human cell line U-2 OS shows positivity in cytoplasm.
- Sample type
- Human